Recombinant Cytokines and Pulmonary Host Defense
- 30 November 1993
- journal article
- review article
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 306 (5), 330-335
- https://doi.org/10.1097/00000441-199311000-00012
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Recombinant Human Interferon- as Adjunct Therapy for Aspergillus Infection in a Patient with Chronic Granulomatous DiseaseThe Journal of Infectious Diseases, 1991
- Chronic neutropenia. A new canine model induced by human granulocyte colony-stimulating factor.JCI Insight, 1991
- Adaptation to bacterial lipopolysaccharide controls lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages.JCI Insight, 1990
- Treatment of Visceral Leishmaniasis with Pentavalent Antimony and Interferon GammaNew England Journal of Medicine, 1990
- Protective effects of recombinant human tumour necrosis factor α and interferon γ against surgically simulated wound infection in miceBritish Journal of Surgery, 1989
- Recombinant Human GM-CSF in Myelosuppression of Chemotherapy (Continued)New England Journal of Medicine, 1989
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Chemotherapy-Induced MyelosuppressionNew England Journal of Medicine, 1988
- ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASEThe Lancet, 1987
- Secretory products of macrophages.JCI Insight, 1987
- Recombinant Human Granulocyte Colony-Stimulating Factor: Effects on Normal and Leukemic Myeloid CellsScience, 1986